Equities Analysts Issue Forecasts for Lam Research Co.’s Q1 2026 Earnings (NASDAQ:LRCX)

Lam Research Co. (NASDAQ:LRCX) – Zacks Research upped their Q1 2026 earnings per share (EPS) estimates for shares of Lam Research in a research note issued to investors on Thursday, April 18th. Zacks Research analyst R. Department now forecasts that the semiconductor company will earn $9.08 per share for the quarter, up from their prior forecast of $9.02. The consensus estimate for Lam Research’s current full-year earnings is $28.92 per share. Zacks Research also issued estimates for Lam Research’s Q2 2026 earnings at $9.94 EPS.

A number of other analysts have also recently weighed in on the company. UBS Group increased their price objective on Lam Research from $885.00 to $1,130.00 and gave the stock a “buy” rating in a research report on Tuesday, March 5th. Deutsche Bank Aktiengesellschaft initiated coverage on Lam Research in a research report on Thursday, April 11th. They set a “hold” rating and a $1,000.00 price objective for the company. Needham & Company LLC increased their price objective on Lam Research from $900.00 to $1,030.00 and gave the stock a “buy” rating in a research report on Thursday, April 18th. B. Riley raised Lam Research from a “neutral” rating to a “buy” rating and raised their price target for the company from $870.00 to $1,100.00 in a report on Friday. Finally, TD Cowen raised their price target on Lam Research from $710.00 to $975.00 and gave the company an “outperform” rating in a report on Thursday, January 25th. Seven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $931.85.

Lam Research Stock Down 0.3 %

Shares of NASDAQ LRCX opened at $868.07 on Monday. The stock has a market cap of $113.80 billion, a PE ratio of 33.57, a price-to-earnings-growth ratio of 3.15 and a beta of 1.51. The company has a quick ratio of 2.02, a current ratio of 3.06 and a debt-to-equity ratio of 0.61. Lam Research has a 52-week low of $493.42 and a 52-week high of $1,007.39. The business has a 50-day moving average price of $944.64 and a 200 day moving average price of $804.00.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.06 by $0.46. The firm had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.71 billion. Lam Research had a return on equity of 44.47% and a net margin of 24.15%. The business’s revenue was down 28.8% on a year-over-year basis. During the same period in the prior year, the firm earned $10.71 EPS.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were given a dividend of $2.00 per share. This represents a $8.00 dividend on an annualized basis and a dividend yield of 0.92%. The ex-dividend date was Tuesday, March 12th. Lam Research’s payout ratio is 30.94%.

Insider Transactions at Lam Research

In other news, SVP Seshasayee Varadarajan sold 5,500 shares of Lam Research stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the sale, the senior vice president now directly owns 22,095 shares of the company’s stock, valued at $20,380,648.95. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, CAO Christina Corrreia sold 647 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $972.03, for a total value of $628,903.41. Following the completion of the sale, the chief accounting officer now directly owns 5,541 shares of the company’s stock, valued at $5,386,018.23. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $922.41, for a total value of $5,073,255.00. Following the completion of the sale, the senior vice president now directly owns 22,095 shares of the company’s stock, valued at $20,380,648.95. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,029 shares of company stock valued at $6,559,489. 0.32% of the stock is currently owned by insiders.

Institutional Trading of Lam Research

Several hedge funds and other institutional investors have recently bought and sold shares of LRCX. Orion Capital Management LLC bought a new position in shares of Lam Research during the third quarter valued at approximately $25,000. BluePath Capital Management LLC acquired a new position in shares of Lam Research during the third quarter worth approximately $28,000. DSM Capital Partners LLC acquired a new position in shares of Lam Research during the fourth quarter worth approximately $28,000. OFI Invest Asset Management acquired a new position in shares of Lam Research during the third quarter worth approximately $30,000. Finally, Asset Dedication LLC boosted its position in shares of Lam Research by 56.7% during the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock worth $30,000 after buying an additional 17 shares during the period. 84.61% of the stock is owned by institutional investors.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.